BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 17240464)

  • 1. Effect of demethylasterriquinone b1 in hypertension associated vascular endothelial dysfunction.
    Shah DI; Singh M
    Int J Cardiol; 2007 Sep; 120(3):317-24. PubMed ID: 17240464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Possible role of Akt to improve vascular endothelial dysfunction in diabetic and hyperhomocysteinemic rats.
    Shah DI; Singh M
    Mol Cell Biochem; 2007 Jan; 295(1-2):65-74. PubMed ID: 16841179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Possible role of exogenous cAMP to improve vascular endothelial dysfunction in hypertensive rats.
    Shah DI; Singh M
    Fundam Clin Pharmacol; 2006 Dec; 20(6):595-604. PubMed ID: 17109653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of protein kinase A improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Endothelium; 2006; 13(4):267-77. PubMed ID: 16990183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benfotiamine attenuates nicotine and uric acid-induced vascular endothelial dysfunction in the rat.
    Balakumar P; Sharma R; Singh M
    Pharmacol Res; 2008; 58(5-6):356-63. PubMed ID: 18951979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of fasudil on macrovascular disorder-induced endothelial dysfunction.
    Shah DI; Singh M
    Can J Physiol Pharmacol; 2006; 84(8-9):835-45. PubMed ID: 17111028
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Rho-kinase in experimental vascular endothelial dysfunction.
    Shah DI; Singh M
    Mol Cell Biochem; 2006 Feb; 283(1-2):191-9. PubMed ID: 16444602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible vasculoprotective role of linagliptin against sodium arsenite-induced vascular endothelial dysfunction.
    Jyoti U; Kansal SK; Kumar P; Goyal S
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Feb; 389(2):167-75. PubMed ID: 26497187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of protein tyrosin phosphatase improves vascular endothelial dysfunction.
    Shah DI; Singh M
    Vascul Pharmacol; 2006 Mar; 44(3):177-82. PubMed ID: 16442349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fenofibrate attenuates nicotine-induced vascular endothelial dysfunction in the rat.
    Chakkarwar VA
    Vascul Pharmacol; 2011; 55(5-6):163-8. PubMed ID: 21864717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of phosphatidylinositol 3-kinase-γ inhibitor CAY10505 in hypertension, and its associated vascular endothelium dysfunction in rats.
    Tyagi S; Sharma S; Budhiraja RD
    Can J Physiol Pharmacol; 2012 Jul; 90(7):881-5. PubMed ID: 22731503
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of rosiglitazone in sodium arsenite-induced experimental vascular endothelial dysfunction.
    Kaur T; Goel RK; Balakumar P
    Arch Pharm Res; 2010 Apr; 33(4):611-8. PubMed ID: 20422371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term atorvastatin improves age-related endothelial dysfunction by ameliorating oxidative stress and normalizing eNOS/iNOS imbalance in rat aorta.
    Gong X; Ma Y; Ruan Y; Fu G; Wu S
    Exp Gerontol; 2014 Apr; 52():9-17. PubMed ID: 24463049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin prevents end-organ injury in salt-sensitive hypertension: role of eNOS and oxidant stress.
    Zhou MS; Jaimes EA; Raij L
    Hypertension; 2004 Aug; 44(2):186-90. PubMed ID: 15238570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin restores the impaired vascular endothelium-dependent relaxations mediated by nitric oxide and endothelium-derived hyperpolarizing factors but not hypotension in sepsis.
    Subramani J; Kathirvel K; Leo MD; Kuntamallappanavar G; Uttam Singh T; Mishra SK
    J Cardiovasc Pharmacol; 2009 Dec; 54(6):526-34. PubMed ID: 19755915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Possible involvement of PPARγ-associated eNOS signaling activation in rosuvastatin-mediated prevention of nicotine-induced experimental vascular endothelial abnormalities.
    Kathuria S; Mahadevan N; Balakumar P
    Mol Cell Biochem; 2013 Feb; 374(1-2):61-72. PubMed ID: 23149826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Eur J Pharmacol; 2013 Dec; 721(1-3):365-72. PubMed ID: 24021535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beneficial effect of insulin in hyperhomocysteinemia and diabetes mellitus-induced vascular endothelium dysfunction: role of phosphoinositide dependent kinase and protein kinase B.
    Sharma S; Singh M; Sharma PL
    Mol Cell Biochem; 2011 Feb; 348(1-2):21-32. PubMed ID: 21069435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of glucagon-like peptide- 1 in vascular endothelial dysfunction.
    Goyal S; Kumar S; Bijjem KV; Singh M
    Indian J Exp Biol; 2010 Jan; 48(1):61-9. PubMed ID: 20358868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel role of fenofibrate in preventing nicotine- and sodium arsenite-induced vascular endothelial dysfunction in the rat.
    Kaur J; Reddy K; Balakumar P
    Cardiovasc Toxicol; 2010 Sep; 10(3):227-38. PubMed ID: 20694523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.